Agreed, short term CR would be disappointing, because should...

Agreed, short term CR would be disappointing, because should start getting revenue in the door within a month.
Assuming a net to BOT of 500 per script, doesn't take long for it to add up, and knowing sales ppl, they'll have sales targets as well, so pushing hard for migration to Sofdra, and if 50% of dermatologists have said they are willing to try.
So the roll out is a slower climb, I've waited this long, another few months in the overall scheme is ok by me.

Really looking forward to getting some value attributed to these other pipelines too.

As they say it won't happen overnight but it will happen.